Scrip
Amgen's Nplate approved in EU for chronic ITP
09 February 2009
Malini Guha
Amgen's Nplate (romiplostim) has been approved by the European Commission for refractory chronic immune (idiopathic) thrombocytopenic purpura (ITP) .
The exact indication is for the treatment of splenectomised adult ITP patients who are refractory to other treatments (eg, corticosteroids, immunoglobulins)....
Please Login to read the full article.
09 February 2009
Malini Guha
The exact indication is for the treatment of splenectomised adult ITP patients who are refractory to other treatments (eg, corticosteroids, immunoglobulins)....
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
